Karin Rosen
Chief Tech/Sci/R&D Officer at HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Profile
Currently, Karin Rosen holds the position of Chief Scientific Officer of Horizon Therapeutics Plc. In her past career Dr. Rosen held the position of Senior Vice President-US Medical Affairs at GlaxoSmithKline Plc. She received a doctorate from the University of Lund.
Karin Rosen active positions
Companies | Position | Start |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/11/2020 |
DIAMYD MEDICAL AB | Director/Board Member | 09/03/2023 |
Former positions of Karin Rosen
Companies | Position | End |
---|---|---|
GSK PLC | Corporate Officer/Principal | 31/10/2020 |
Training of Karin Rosen
University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GSK PLC | Health Technology |
DIAMYD MEDICAL AB | Health Technology |
Private companies | 1 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Karin Rosen